The CHST3 gene helps your body build and maintain cartilage, the smooth tissue that cushions joints and supports bone growth. This gene plays an important role in shaping the skeleton during early development. If both copies carry harmful variants, cartilage and bone development can be disrupted, which can lead to short stature, spinal curvature, stiff or enlarged joints, and joints that dislocate easily.
What is a gene?
Genes are sections of DNA that provide cells with instructions for making molecules or managing processes in the body. Some genes hold the information needed to make proteins, which are the working parts of cells. Others mostly help regulate when certain processes take place, where they occur, and how strongly they operate. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. More information about this topic is available in the LearnHub.
Overview
CHST3Gene function
What if the gene works
The CHST3 gene helps make a protein that adds sulfate to cartilage molecules. This supports cartilage that cushions joints and helps bones grow in a balanced way.
Risk
What if the gene does not work
Variants in the CHST3 gene most often cause a condition affecting bone and cartilage growth, with short stature, joint dislocations, and spine curvature. Effects can range from milder to more severe, influencing when symptoms begin and movement.
Treatment
What does that mean for your treatment
No CHST3-specific treatment or drug selection approach is currently established for pathogenic variants in the CHST3 gene. Management is supportive and is tailored to a person's bone and joint needs, rather than changed by the gene result itself.
Conditions associated with CHST3
Gene function
What if the gene works
In joints, growth plates, and other connective tissues, the CHST3 gene helps build the supportive material around cells. It is especially important for making healthy cartilage, which cushions movement and helps bones develop in an organized way. Understanding how the CHST3 gene works can make it easier to see how your body builds flexible, resilient tissue.
The CHST3 gene helps cells add sulfate, a small chemical tag, to chondroitin chains. This step turns them into chondroitin sulfate, an important part of cartilage and other connective tissues.
One of the main jobs of the CHST3 gene is helping create the cartilage material that gives joints smooth, springy support. This is a core part of what the CHST3 gene does in cartilage and connective tissue.
By shaping chondroitin sulfate, the CHST3 gene helps the tissue around cells hold water and stay resilient under pressure. This supports everyday movement and steady bone growth during development.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, and the way the body reacts to environmental factors. Many variants do not cause any noticeable changes and are part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHST3 gene can change the enzyme’s shape, make it unstable, or stop the cell from producing a full working protein. These CHST3 gene variants often reduce sulfation (adding a small chemical tag called sulfate) on key cartilage molecules, which can weaken how cartilage is built and maintained. Milder variants may leave some enzyme activity, while more severe variants can lead to little or no activity. This often influences how early bone and joint changes appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the CHST3 gene cause a rare skeletal condition called spondyloepiphyseal dysplasia with congenital joint dislocations. In practice, CHST3 gene variants linked to conditions mainly affect bone and joint growth, often leading to short stature, spinal curvature, and joints that are unusually loose or dislocated from birth or early childhood. Some people with changes in both copies of the gene are described under the closely related label humero spinal dysostosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. Still, in some situations, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHST3-related conditions, risk is mainly set by the gene changes a child inherits from both parents. The chance is higher in families where both parents carry a CHST3 variant, and this is more likely when parents are blood relatives. There is not enough evidence to say that lifestyle or environmental factors meaningfully change this risk.
Inheritance of CHST3 variants
CHST3-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one CHST3 gene variant from each parent. Parents who carry one variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with no familial CHST3 variant. Sons and daughters are affected equally because the CHST3 gene is not on a sex chromosome.
What does my CHST3 result mean for my family?
For CHST3, family implications usually fit a recessive pattern. This often means parents are healthy carriers, and brothers or sisters may also be affected or may be carriers even if they have no symptoms. Other close relatives, such as siblings of the parents, may also carry the same change, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, genetic testing for CHST3 variants usually analyzes DNA from a blood sample or saliva. A lab reads the CHST3 gene to look for changes that may explain a person’s skeletal condition and helps show whether a result confirms the diagnosis or is uncertain.
When should I consider getting a genetic test?
If a child has clear signs of a bone growth condition, such as short stature, frequent joint dislocations, or early spine and hip changes, testing the CHST3 gene may help confirm the cause. It can also be useful when these features run in the family or when both parents are known carriers.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. In many cases, small inherited differences influence how the body handles a drug or how strongly the body responds to it, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It focuses on the links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can support more informed and more personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CHST3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about side effects, new symptoms, or how medicines may affect your overall health are best discussed with your doctor or pharmacist.
History
Researchers identified the CHST3 gene during the broader effort to map genes involved in inherited skeletal conditions. Building on this early work, clinicians soon linked CHST3 variants to families with short stature, spine changes, and joint problems present from early life. These reports helped define a recognizable group of conditions that had previously been described mainly by physical features and X ray findings. As genetic testing became more widely used, CHST3 was added to testing panels for bone and cartilage conditions, making diagnosis more precise for some families. Over time, scientists’ understanding of the CHST3 gene has changed as more affected people and more variant types were described.